U.S. health insurers are shedding pandemic‑era losses as medical costs rise slower than feared and Washington relaxes Medicare Advantage rules. Share prices of United Health Group, Humana and CVS Health, once trampled, have surged, signaling a shift back to profitability for the sector.

The rebound follows a period when insurers over‑priced plans for a calmer market, then faced a flood of patients returning to care after COVID‑19. Washington tightened Medicare Advantage payments, squeezing margins. Now, with costs cooling, the once‑shunned industry is regaining footing, sparking renewed investor interest for policyholders and shareholders across the sector.

United Health Group’s shares climbed 12% this quarter, while Humana rose 9% and CVS Health gained 7%, reflecting improved earnings forecasts. Analysts view the recovery as a sign that Medicare Advantage’s vulnerability has eased, but they warn that future earnings reports will test whether the upside can sustain long.

Investors eye the upcoming second‑quarter earnings for a clearer picture of cost dynamics and margin rebound. If insurers can keep medical spending in check while maintaining premium growth, the sector may solidify its position as a income stream. The current gains, however, may already be priced in in the market.